Skip to main content
NCBI home page
Saudi Pharmaceutical Journal : SPJ logoLink to Saudi Pharmaceutical Journal : SPJ
. 2020 Nov 26;28(12):1834–1841. doi: 10.1016/j.jsps.2020.11.010

Evaluation of microalgae and cyanobacteria as potential sources of antimicrobial compounds

Faisal Alsenani a,b,c,⁎, Karnaker R Tupally b, Elvis T Chua c, Eladl Eltanahy d, Hamed Alsufyani e, Harendra S Parekh b, Peer M Schenk c
PMCID: PMC7783216  PMID: 33424272

Graphical abstract

graphic file with name ga1.jpg

Open in a new tab

Keywords: Antimicrobial, Bioactive compounds, Microalgae, Natural products

Highlights

  • •

    Three microalgal extracts show antimicrobial activity against gram-positive bacteria.

  • •

    Different purification techniques were used to reveal the bioactive compounds.

  • •

    Linoleic acid, oleic acid, DHA and EPA inhibited the growth of gram-positive bacteria.

Abstract

In recent decades, marine microorganisms have become known for their ability to produce a wide variety of secondary bioactive metabolites. Several compounds have been isolated from marine microorganisms for the development of novel bioactives for the food and pharmaceutical industries. In this study, a number of microalgae were evaluated for their antimicrobial activity against gram-positive and gram-negative bacteria, including food and plant pathogens, using various extraction techniques and antimicrobial assays. Disc diffusion and spot-on-lawn assays were conducted to confirm the antimicrobial activity. To measure the potency of the extracts, minimum inhibition concentrations (MIultCs) were measured. Three microalgae, namely Isochrysis galbana, Scenedesmus sp. NT8c, and Chlorella sp. FN1, showed strong inhibitory activity preferentially against gram-positive bacteria. These microalgal species were then selected for further purification and analysis, leading to compound identification. By using a mixture of different chromatography techniques gas chromatography–mass spectrometry (GC–MS) and high-performance liquid chromatography (HPLC) and ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), we were able to separate and identify the dominant compounds that are responsible for the inhibitory activity. Additionally, nuclear magnetic resonance (NMR) was used to confirm the presence of these compounds. The dominant compounds that were identified and purified in the extracts are linoleic acid, oleic acid, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). These compounds are the potential candidates that inhibit the growth of gram-positive bacteria. This indicates the potential use of microalgae and their antimicrobial compounds as biocontrol agents against food and plant pathogens.

1. Introduction

In the last few decades, bacteria have increased their resistance to antibiotics, and they have become a major concern for public health because the antibiotics are losing their effectiveness at alarming rates due to the development of antibiotic-resistant microorganisms (Monnet et al., 1998, O’Neill, 2016). Treating infectious diseases, especially diseases caused by resistant pathogens, is becoming one of the largest healthcare challenges worldwide. Resistance to antibiotics has emerged in major bacterial species; some of these species are now likely to be resistant to most/all available antimicrobials, creating an ‘antibiotic resistance crisis’ (Rossolini et al., 2014). By 2050, it is expected that the human cost of this crisis will reach 300 million premature deaths, with the worldwide economy losing $100 trillion as a result (Arias and Murray 2015). A major collaboration between the nations of the world and various branches of science is required to face this problem (Berendonk et al., 2015). Therefore, the World Health Organization (WHO) initiated a worldwide plan (Organization 2015) that many countries are following. However, the use of antibiotics in areas such as pharmaceuticals, agriculture, aquaculture, and manufacturing still affect the environment in critical ways (Topp et al., 2018). Moreover, the effort to discover new antimicrobial compounds in recent decades has been met with countless challenges and, in many cases, failure. In the golden years of antibiotic discovery, the process typically consisted of culture screening wastewater/soil-derived organisms for activity against other microorganisms. However, these discoveries proved cumbersome and were effectively exhausted by the 1970s due to the repeated identification of similar compounds.

To address this, attention has turned to alternative sources such as marine life, which provides a rich and diverse array of novel, biologically active compounds. Recently, marine organisms research has increased in research markets (Jena and Subudhi 2019). A number of chemically unique metabolites with different biological activity among marine origins, such as those from microalgae, have been isolated and developed as food and pharmaceutical products (Faulkner, 2000, Schwartsmann et al., 2001). The use of microalgae as an alternative source of antibiotics and preservatives has attracted similar attention. Eukaryotic and prokaryotic microalgae produce a wide range of biologically active compounds. These compounds include toxins, algaecides, plant-growth regulators and, most importantly, those with uses in the food and pharmaceutical industries (Żak et al., 2015, Bhattacharjee, 2016).

Currently, microalgae and cyanobacteria are receiving a high level of attention from manufacturers and researchers alike. Based on the widely biodiverse properties of these microorganisms, they are expected to be strong commercial sources of high-value bioactive compounds. In particular, the antimicrobial properties of microalgae and cyanobacteria have been examined for their potential use as pharmaceutical antimicrobial compounds and food preservatives (Mendiola et al., 2007).

Some of the antimicrobial activities of microalgae and cyanobacteria have been linked to unsaturated fatty acids. The first such antimicrobial compound, chlorellin, was isolated from Chlorella sp.; it is a mixture of fatty acids that inhibit the growth of both gram-positive and gram-negative bacteria (Pratt et al., 1944). Furthermore, eicosapentaenoic acid (EPA), hexadecatrienoic acid and palmitoleic acid isolated from Phaeodactylum tricornutum have been shown to possess antimicrobial activity against methicillin-resistant gram-positive Staphylococcus aureus (Benkendorff et al., 2005, Smith et al., 2010). Similarly, unsaturated fatty acids from Scenedesmus intermedius, Chaetoceros muelleri, Haematococcus pluvialis, Chlorococcum sp. and Skeletonema costatum were also found to have antimicrobial effects against a wide range of gram-positive and gram-negative bacteria. In addition, organic extracts obtained from Euglena viridis and S. costatum showed inhibitory activity against Pseudomonas sp. and Listeria monocytogenes (Das et al., 2005, Terekhova et al., 2009). Ethanolic extracts from Isochrysis galbana and Dunaliella salina were also found to be active against four different bacterial strains with an inhibitory concentration (IC50) of 100, 80 µg/ml, respectively (Verma et al., 2016). Coccomyxa onubensis fatty acids extracts showed inhibition against a different range of gram-positive and gram-negative bacteria and fungi, with a lowest minimum inhibition concentration (MIC) of 305 and 106 µg/mL against E.coli and P. mirabilis, respectively (Navarro et al., 2017). Additionally, the pressurised liquid extracts of Fucus vesiculosus produced long-chain fatty acids that showed inhibition against E. coli (IC50 = 2.24 mg/mL) and S. aureus (IC50 = 1.27 mg/mL; (Otero et al., 2018). Another study found that Rivularia mesenterica ethanolic extract has a strong inhibitory effect against different antibiotic-resistant bacteria and fungi and the MIC ranged between 0.06 and 32.00 µg/mL (Skočibušić et al., 2019). Novel antimicrobial compounds have also been identified from microalgae and cyanobacteria; such a compound, EMTAHDCA, was isolated from Nostoc sp. and has a strong binding affinity to the protein of the targeted bacteria (Verma et al., 2016).

Microalgae and cyanobacteria have also shown antifungal and antiviral activity against a wide range of microorganisms. Ghasemi et al. (2007) reported that methanol and hexane extracts of Chlamydomonas reinhardtii, Chlorella vulgaris, Scenedesmus obliquus and Oocystic sp. prevent the growth of Aspergillus niger, Candida kefyr and Aspergillus fumigatus. Karatungiols extracted from Amphidinium sp. are responsible for growth inhibition in Aspergillus niger and Trichomonas foetus (Washida et al., 2006). On the other hand, several studies have found virus growth-inhibitory compounds in microalgae. For instance, sulphated polysaccharide compounds isolated from Navicula directa and Chlorella autotrophica inhibit the replication of and hyaluronidase the enzymes in VHSV, ASFV, HSV1 and 2 and the influenza A virus (Fábregas et al., 1999, Lee et al., 2006). The aim of the present study was to purify, screen and evaluate different microalgal species for their ability to produce antimicrobial compounds.

2. Materials and methods

2.1. Chemicals

Chemicals were analytical or HPLC grade; they were purchased from Merck (Bayswater, VIC, Australia) and Sigma-Aldrich (Castle Hill, NSW, Australia). Bacterial growth discs were purchased from Edwards Group (Narellan, NSW, Australia).

2.2. Algal strains and growing conditions

Fourteen microalgal and two cyanobacterial strains from the Algae Biotechnology Laboratory collection (University of Queensland (UQ)) were screened for antimicrobial activity (Table 1). The microalgal strains that were used were Pavlova lutheri, Chaetoceros muelleri, local Chlorella sp. PH1, local Chlorella sp. FN1, Chlorella vulgaris, Chlorella sp. BR2, Dunaliella tertiolecta, Haematococcus pluvialis, Isochrysis galbana, Nannochloropsis sp. BR2, Scenedesmus sp. NT8c, Tetraselmis astigmatica, Tetraselmis chuii and Tetraselmis suecica. The cyanobacterial strains were Limnothrix sp. and Spirulina sp.

Table 1.

List of algal strains studied.

Algal strain Origin/source GenBank Water type/Media Temperature °C
Pavlova lutheri Queensland Sea Scallops Trading Pty Ltd (QSST)/UK JQ423159 Marine/F/2 28
Chaetoceros muelleri QSST, CSIRO, Tasmania (CS-176)/ Oceanic Institute, Hawaii, USA JQ423153 Marine/F/2 + Si 28
local Chlorella sp. PH1 Brisbane River NA Brackish/ TP, TAP 28
local Chlorella sp. FN1 Brisbane River MK488058.1 Brackish/ TP, TAP 28
Chlorella vulgaris Brisbane River NA Marine/F/2 28
Chlorella sp. BR2 Brisbane River JQ423156 Brackish/ TP, TAP 28
Dunaliella tertiolecta CSIRO, Tasmania (CS-175/8)/ NA Marine/F/2 28
Haematococcus pluvialis CSIRO, Tasmania (CS-321/8)/ NA Fresh/BBM 28
Isochrysis galbana QSST/UK JQ423157 Marine/F/2 28
Nannochloropsis sp. BR2 Brisbane River JQ423160 Brackish/F/2 28
Scenedesmus sp. NT8c Northern Territory KF286271.1 Fresh/BBM 28
Tetraselmis astigmatica Maroochydore, Australia NA Marine/F/2 28
Tetraselmis chuii QSST/CSIRO, Tasmania (CS-26)/ East Lagoon, Galveston, TX, USA JQ423150 Marine/F/2 28
Tetraselmis suecica QSST/CSIRO, Tasmania (CS-187)/ Brest, France JQ423151 Marine/F/2 28
Limnothrix sp. Brisbane River NA Marine/F/2 28
Spirulina sp. CSIRO, Tasmania (CS-785/02/8) NA Fresh/BBM 28
Open in a new tab

NA: not applicable.

Microalgae were sub-cultured from master cultures in 2 L conical flasks with an f/2 medium (AlgaBoostTM F/2 2000x; Ausaqua Pty Ltd, Wallaroo, SA, Australia) for marine microalgae and Bold’s basal medium (BBM) for freshwater microalgae (Stein 1973). The different microalgal species were cultured according to Alsenani et al. (2019). After algae growth reached the late exponential phase, cultures were transferred to 20 L bioreactors under the same conditions once the optical density (OD) at 440 nm reached 2.5. Then, they were transferred to the UQ Algae Energy Farm in Pinjarra Hills, Brisbane, Australia to test the reproducibility of the antimicrobial compounds on an industrial scale and in an outdoor environment. Cultures were grown outdoors in a 2 m closed photobioreactor comprising 200 L transparent bag towers with a 36 cm diameter, and the temperature varied between 23.6 °C during the daytime to 13.9 °C at night, with a 12/12 h light cycle. Cultures were harvested via centrifugation for 5 min at 3000g, then washed with Milli-Q water. Each harvested biomass was divided into two batches: the first batch was used directly for antimicrobial assays, while the second batch was freeze-dried and then stored at −80 °C before the extraction process. In addition, the supernatants were collected and stored at −20 °C to be tested for extracellular antimicrobial activity.

2.3. Extraction methods

Various extraction systems and methods were used to screen the bioactive compounds. The solvent systems used included ethyl acetate, acetonitrile, acetone, chloroform, methanol, ethanol, dichloromethane, dimethyl sulfoxide (DMSO), n-hexane, water, chloroform + methanol (2:1, v/v) and water + methanol (1:3, v/v). Method (a): 1 mL of each solvent was added to 10 mg of algal biomass (dry weight (DW)) in a porcelain mortar and the mixture was ground. The extracts were then transferred to 2 mL tubes and shaken for 90 min at room temperature. The tubes were centrifuged (5000g; 1 min), and the supernatants (i.e., intracellular extracts) were collected and transferred to another set of 2 mL tubes. Method (b): 10 mL of each solvent was added to 1 g DW of algal biomass and vortexed for 30 s before being incubated overnight in dark conditions to prevent light-sensitive compounds from degradation. After centrifugation, the extracts were transferred to new tubes and the solvents were completely evaporated via rotary evaporation. Then, the crude extracts were redissolved in 200 µL of the selected solvents. Method (c) involved subsequent extraction with a four-solvent system composed of water + methanol (1:3, v/v), chloroform, ethyl acetate and acetone, in that order. Each extraction step involved incubation overnight in dark conditions. The extract of each solvent was evaporated via rotary evaporation. The dried extracts were resuspended in 200 µL of the same solvent system. All extracts were stored at −20 °C and protected from direct light at all times.

The active crude extracts were fractionated using hexane, dichloromethane and methanol. Antimicrobial assays were then performed for each fraction, and the active fractions were taken for further analyses.

2.4. Target pathogens

Gram-positive human and plant pathogenic bacterial strains included Listeria monocytogenes (ATCC 7644), Staphylococcus aureus (ATCC 25925 and ATCC 9144), Bacillus subtilis (ATCC 6633 and ATCC 6051), Staphylococcus epidermidis, Enterococcus faecalis and Clavibacter michiganensis and the gram-negative bacteria that were tested were Escherichia coli (ATCC 25922), Salmonella typhoid (ATCC 14028), Pseudomonas syringae, and Proteus vulgaris.

2.5. Antimicrobial assays

Both extra- and intracellular extracts of the selected microalgae and cyanobacteria were screened for their antimicrobial activity against the selected bacteria. The disc-diffusion method and the spot-on-lawn method were used to ensure the accuracy of the results. First, the disc-diffusion method was conducted by pouring tryptone soya agar (TSA) onto the plates and waiting for 20 min for solidification. Then the stock cultures were inoculated by spreading over the medium. Discs were loaded with 20 µL of the various microalgal extracts, allowed to dry, and then placed over the TSA using sterile forceps. After overnight incubation at 28 °C or 37 °C (depending on the bacteria), an inhibition zone was observed as a sign of antimicrobial activity. Second, the spot-on-lawn method was conducted by adding 10 µL of the selected bacteria to 7 mL of 0.7% TSA medium and pouring it on top of the solidified TSA plate. Then, 20 µL of various microalgal extracts were spotted onto the plates and allowed to dry for 45 min. Inhibition zones were observed after overnight incubation. Negative controls were used in each assay. The experiments were conducted in triplicate, and for each sample and the average diameter of the inhibition zone of each triplicate was calculated.

2.6. Minimum inhibition concentration (MIC)

The bacterium to be tested was streaked onto a tryptic soy agar plate and incubated at 28 °C or 37 °C for 24 h. One colony was then transferred to fresh tryptic soy broth (Difco, USA) (15 mL) and the cell density was adjusted to 104–105 colony-forming units (cfu)/mL. Test extracts were dissolved in 100% dimethyl sulfoxide (DMSO) and diluted with sterilised deionised water to 10% DMSO. The stock solution was diluted with 10% DMSO to give final concentrations of 1% DMSO. The extract concentrations were then serially diluted to 500, 250, 150, and 100 µg extracts/mL of 1% DMSO. Each dilution was transferred to a 96-well microtiter plate and freshly prepared microbial broth was added to each well. Negative growth controls contained only growth media, and positive growth controls contained growth media and bacterial suspension. The plates were incubated at 37 °C for 24 h, and the optical density of each well was measured spectrophotometrically at 600 nm (using POLARstar Omega Plate, BMG LABTECH, Offenburg, Germany). MIC values were determined after overnight incubation and recorded as the lowest concentration of each test solution that inhibited the growth of all the microorganisms in the wells. The experiments were conducted in triplicate for each sample and the average concentration of each triplicate was calculated.

2.7. GC–MS analysis

A Shimadzu GCMS-QP2010 ULTRA system was used to analyse and quantify the fatty acid content of each microalgal oil extract. The analysis method was adopted from Chua et al., 2018, Ma et al., 2018.

2.8. HPLC

Each active fraction was checked using a Shimadzu Nexera-i LC-2040C 3D analytical HPLC system equipped with a quaternary solvents delivery system, an online degasser, an autosampler, a column temperature of 22 °C and a photo-diode array detector (200–800 nm) coupled with an analytical workstation. Aliquots of the active fractions were redissolved in methanol, and 10 μL of these aliquots were injected into the HPLC system. Chromatographic separation was conducted on a Jupiter C4 microbore column (2 × 150 mm, 5-μm particle diameter, 100 Å pore size, Phenomenex, Belmont, CA, USA) using gradient elution consisting of 0.1% formic acid (aq) (A) and acetonitrile (B). The 110 min gradient was as follows: 0 min, 100% phase A; 90 min, 100% phase B; 110 min, 100% phase B. The flow rate was 0.2 mL/min. A 0.2 µm polytetrafluoroethylene (PTFE) membrane filter (Phenomenex, Torrance, CA, USA) was used to filter the samples before injection.

2.9. UHPLC-Q-TOF-MS analysis

Each fraction was analysed using an Agilent UHPLC-Q-TOF-MS system (Agilent Technologies, Santa Clara, CA, USA) to obtain the molecular weights of the components. The same elution gradient programme and solvents system as with the HPLC were used. The analysis method was adapted from Bose et al. (2015). Slight changes were made as follows: the sample volume was 100 μL, the capillary voltage was 2000 V, drying gas was 5.0 L min−1 and the fragmentor voltage was 150 V.

2.10. NMR analysis of crude extracts

Crude hexane extracts of active fractions were dissolved in approximately 1 mL of deuterated chloroform with 0.05% tetramethylsilane, transferred to a 5 mm NMR sample tube, and subjected for 1H and 13C NMR analysis in a 500 MHz Bruker Avance 500 high-resolution NMR spectrometer. For the 1H NMR analysis, 32 scans were averaged, while for the 13C NMR analysis, 1024 scans were averaged.

3. Results

3.1. Screening of microalgal extracts against human and plant pathogens

Among the various microalgae and cyanobacteria examined, three species, namely I. galbana, Scenedesmus sp. NT8c, and Chlorella sp. FN1, showed activity against gram-positive pathogens on plate growth inhibition assays (Fig. 1, Table 2). Different solvent extracts had different levels of antimicrobial activity against specific pathogens. Of all the extracts, the I. galbana ethanolic extract showed the highest level of antimicrobial activity against L. monocytogenes, though less activity was observed with the ethyl acetate extract when using a disc-diffusion assay. Moreover, using the spot-on-lawn method showed additional slight growth inhibition activity with the ethanol extract of I. galbana against S. aureus. However, no other extracts showed any activity when using the disc-diffusion method.

Fig. 1.

Fig. 1

Open in a new tab

Inhibition zones of Staphylococcus aureus and Listeria monocytogenes growth. 1: I. galbana crude extract; 2: I. galbana n-hexane fraction; 3: Scenedesmus sp. NT8c crude extract; 4: Scenedesmus sp. NT8c n-hexane fraction; 5: Chlorella sp. FN1 crude extract; 6: Chlorella sp. FN1 n-hexane fraction.

Table 2.

Summary of antimicrobial activities of various species. Shown are mean values ± SD from three separately cultures.

Species I. galbana Chlorella sp. FN1 Scenedesmus sp. NT8c
Extracts 100% ethyl acetate 100% ethanol 70% methanol in water 70% methanol in water
Fractions Hexane Hexane Hexane
Target pathogens L. monocytogenes 12.67a(±0.58) 19.67 (±0.58)* 16.67(±0.58)* 18.3(±1.15)*
S. aureus – 20(0)* 16.33(±0.58)* 17.67(±1.53)*
B. subtilis – 19.33(±0.58)* 15.67(±1.15)* 18.33(±1.15)*
E. coli – – – –
S. typhoid – – – –
P. syringae – – – –
C. michiganensis – 16.33(±2.31)* 18.67(±1.53)* 17(0)*
S. epidermidis – 18.33(±0.58)* 16.67(±0.58)* 16.67(±0.58)*
E. faecalis – 19.33(±1.15)* 19.67(±0.58)* 18.33(±1.15)*
Open in a new tab

(–) No zone of inhibitions were observed.

a

Mean diameter of triplicates inhibition zones were calculated.

*

Values indicate statistically significant differences (T-test; p < 0.05).

Using the spot-on-lawn method showed more growth inhibition activity by various extracts. Extracts of all three microalgal species showed a strong inhibition effect against all gram-positive bacteria (Fig. 1). Nevertheless, no antimicrobial activity was observed with all extracts against gram-negative pathogens. Also, both fresh microalgal biomass and supernatants showed negative results against all pathogens.

3.2. Minimum inhibition concentration (MIC)

The MICs of the extracts were measured using serial dilutions up to 100 µg of extracts /mL of 1% DMSO. The active growth inhibition concentrations for the microalgae tested ranged from 500 µg/mL to 1 mg/mL. The MIC for I. galbana was 500 µg/mL and was 1 mg/mL for Chlorella sp. FN1 and Scenedesmus sp. NT8c. There was no sign of growth inhibition below the mentioned concentrations of 100 µg/mL. The lowest concentrations that inhibited all bacterial growth and had clear solutions were identified and measured.

3.3. GC–MS analysis

In an attempt to identify the compounds responsible for the antimicrobial activity found in the microalgae, GC–MS was used to characterise the extracts. The GC–MS results showed various fatty acids methyl esters (FAME) contents and profiles for different species. The highest amount of α-linolenic acid as a FAME percentage was found in Chlorella sp. FN1 (68.3%), while I. galbana had the highest amount of oleic acid (34.85%), and Chlorella sp. FN1 had the highest amount of linoleic acid (12.09%). Additionally, hexadecaenoic acid, oleic acid, linoleic acid and α-linolenic were detected in all three species in various concentrations while eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were found only in I. galbana (0.86% and 24.61%, respectively) as shown in Table 3 and Fig. 2.

Table 3.

GC–MS identification of fatty acids methyl esters (FAME) detected in microalgal species, showing mean values ± SEs as mg/g dry weight from three separately grown cultures (n = 3).

Fatty acids I. galbana Scenedesmus sp. NT8c Chlorella sp. FN1
Palmitic acid C16:0 24.73 ± 1.07 21.73 ± 0.76 24.60 ± 1.02
Hexadecanoic acid C16:1 10.64 ± 0.57 9.48 ± 0.54 9.16 ± 0.27
Octadecanoic acid C18:0 0.86 ± 0.06 0.53 ± 0.04 0.58 ± 0.08
Oleic acid C18:1 39.60 ± 2.02 4.25 ± 0.1 10.93 ± 0.39
Linoleic acid C18:2n6 3.53 ± 0.04 6.36 ± 0.22 28.54 ± 0.96
α-Linolenic acid C18:3n3 5.33 ± 0.46 28.57 ± 0.37 158.54 ± 3.38
EPA C20:5n5 0.98 ± 0.13 n.d. n.d.
DHA C22:6n3 27.96 ± 2.73 n.d. n.d.
Open in a new tab

n.d. – not detected.

Fig. 2.

Fig. 2

Open in a new tab

Percentage of individual FAME detected in each microalgal species.

3.4. HPLC analysis

The HPLC chromatograms of representative batches of crude n-hexane fractions of I. galbana and Scenedesmus sp. NT8c are shown in Fig. 3 A and B, respectively. The chromatograms show that most of the peaks appeared late in the run, after solvent B reached 50% (>50 min). The I. galbana chromatogram displayed two large peaks eluting about 70 and 86 min with concentrations of 13% and 32% of the total peak areas, while Scenedesmus NT8c showed multiple prominent peaks eluting at about 59, 66, 83 and 86 min with concentrations of 12%, 6%, 11% and 25%, respectively, of the total compounds and other relatively smaller peaks. The n-hexane fraction of the Chlorella sp. FN1 chromatogram showed a large peak eluting at about 54 min with a concentration of 41%, which most likely could be the one that produces the activity, while the other peaks were minor and of similar intensity (Fig. 3 C).

Fig. 3.

Fig. 3

Open in a new tab

HPLC chromatogram of the crude n-hexane fractions of the three microalgae tested.

3.5. UHPLC-Q-TOF-MS analysis

The mass spectra were acquired for each component in the samples. Different mass spectra were measured with each fraction. Table 4 shows the molecular weights for each fraction. The mass spectra show the detected fatty acids that potentially mediate the growth-inhibition effect. Oleic acid is combined with stearic acid in a triglyceride form in all species. Additionally, pheophytin a also was detected in both I. galbana and Chlorella sp. FN1. Linolenic acid was detected in I. galbana as a form of triglyceride.

Table 4.

Summary of the detected compounds by UHPLC-Q-TOF-MS.

Species Retention time (min) M.W. (g/mol) Compounds
I. galbana 61.9
71
70		 872.6063
887.5727
871.5713		 Trilinolenic glyceride
C18:0 + C18:1 + C18:1
pheophytin a
Scenedesmus sp. NT8c 43
43.9
70		 263.2006
284.3318
887.5691		 α-Linolenol
Stearic acid (C18:0)
C18:0 + C18:1 + C18:1
Chlorella sp. FN1 62

71
72		 587.4677

887.5682
871.5767		 Hexadecanoic acid, 1, 1′-[1-(chloromethyl)-1,2-ethanediyl] ester
C18:0 + C18:1 + C18:1
pheophytin a
Open in a new tab

3.6. NMR analysis of crude extracts

1H NMR analysis of the n-hexane extracts showed the presence of aliphatic –CH3 and —CH2 protons from the peaks in the range of 0.5–2 ppm. These protons could be attributed to the presence of lipids in the form of triglycerides or the methyl groups of carotenoids. The presence of carotenoids in the extracts was further verified by the peaks at around 5.4 ppm due to the Created by potrace 1.16, written by Peter Selinger 2001-2019 CH— protons, which are abundant in carotenoids. This set of peaks can also be attributed to the methylene protons of polyunsaturated fatty acids (Supplementary Fig. 1).

13C NMR analysis confirmed the presence of lipids and carotenoids. Peaks in the range of 10–40 ppm were due to the alkyl carbon groups, which are the terminal and mid groups in fatty acids and carotenoids. Alkene carbons are present around 130 ppm, which is characteristic of polyunsaturated fatty acids and carotenoids. The carbon attached to an alcohol is found in 50–52 ppm. This alcohol can be attributed to the alcohol groups attached to carotenoids like zeaxanthin in I. galbana or lutein in Scenedesmus sp. NT8c and Chlorella sp. FN1 or the alcohol groups from the glycerol backbone of mono- and diglycerides. Finally, the carbonyl group peaks of either carotenoids (e.g. fucoxanthin) or fatty acids are found in 180–190 ppm (Supplementary Fig. 2).

4. Discussion

There have been numerous studies of the antimicrobial activity of microalgae and cyanobacteria. The first antimicrobial compound discovered in microalgae was chlorellin, which was isolated from Chlorella sp. (Pratt et al., 1944). In addition, fatty acids, carotenoids, phycobiliproteins, and chlorophyll derivatives have been identified as key bioactive compounds in microalgae and cyanobacteria (Jørgensen, 1962, Bruce et al., 1967, Najdenski et al., 2013, Kasanah et al., 2019). Maadane et al. (2020) evaluated the antimicrobial activity of I. galbana and found that it had a strong inhibition effect on bacteria and fungi with a MIC that ranged between 2.6 and 4.3 mg/mL and activity linked to fatty acids and carotenoids contents In their study, the n-hexane fraction I. galbana also inhibited the growth of gram-positive bacteria. It has also been reported that the short and long-chain fatty acids from H. pluvialis and Scenedesmus obliquus are responsible for growth inhibition against B. subtilis, S. aureus and E. coli (Santoyo et al., 2009, Rodríguez-Meizoso et al., 2010, Catarina Guedes et al., 2011, Bashir et al., 2018). Surendhiran et al. (2014) reported that fatty acids from Nannochloropsis oculata showed activity against gram-positive and gram-negative bacteria. Moreover, Bruce et al. (1967) claimed that I. galbana had antimicrobial activity caused by pheophytin a and chlorophyllide a by showing a slight inhibition of S. aureus and strong inhibition of a wide range of gram-negative bacteria. These results were confirmed by Dvoretsky et al. (2019) who established that the inhibitive properties of Chlorella sp. were caused by fatty acids compounds. Mass spectrometry of the Chlorella sp. FN1 n-hexane fraction showed that it contained pheophytin a, which is consistent with Bruce et al. (1967) who detected the same compound in I. galbana and suggested that it was responsible for the antimicrobial activity. These results are also consistent with a study that performed antimicrobial screening on Chlorella salina and I. galbana and found that both had a strong inhibitory effect on pathogenic bacteria (Srinivasakumar and Rajashekhar, 2009).

In the current study, strong antimicrobial activity of various extracts has been observed against gram-positive bacteria. The strength of the activity was based on the minimum inhibition concentration (MIC) – the lowest concentration of extract that completely inhibits the growth of the bacteria compared with other extracts. The mechanism for antimicrobial activity of long-chain fatty acids (LC-FA) is not yet fully characterised, but it seems that interfering with the elongation process in the biosynthesis of bacterial fatty acids might be the inhibiting factor effect (Heath et al., 2001, Payne et al., 2001). In addition, it was claimed that the growth inhibition action due to the deleterious effect of fatty acids causes cell leakage of the bacterial cell membrane, or nutrient intake disruptions (Jüttner, 2001, Smith et al., 2010). The difference between gram-positive and gram-negative bacteria is the structure of the cell wall. The outer membrane of gram-negative species acts as an envelope. It is a system with multiple layers that include the outer membrane, the peptidoglycan cell wall, and the cytoplasmic membrane (the inner membrane) (Exner et al., 2017). This outer membrane works as a barrier to permeable compounds, and it excludes certain ones like antibiotics from penetrating the cell (Silhavy et al., 2010). This function of the outer cell wall explains why gram-positive species were more susceptible and less resistant to antibiotics than gram-negative bacteria.

Following the initial profiling of LC-FAs in the active microalgae strains, oleic acid, DHA, palmitic acid, α-linolenic acid, and linoleic acid were detected. In several studies, linoleic acid and oleic acid have been proven to have antimicrobial activity from different sources (Dilika et al., 2000, Agoramoorthy et al., 2007, Kasanah et al., 2019). All the strains contained a high amount of palmitic acid, but saturated fatty acids showed little or no antimicrobial activity (Galbraith et al., 1971). To possess antimicrobial activity, the compounds must be water-soluble and remain sufficiently lipophilic so they can be adsorbed onto the cell surface, but this is not the case with saturated fatty acids. The presence of DHA in I. galbana might be the reason for the strong activity, along with linoleic acid and oleic acid, since DHA has inhibitory effects against gram-positive bacteria (Shin et al., 2007). Mass spectrometry and 1H and 13C NMR spectra have confirmed the presence of the measured fatty acids, which confirms the hypothesis of this study. Mass spectrometry detected oleic acid and linolenic acid in I. galbana and oleic acid in Scenedesmus sp. NT8c and Chlorella sp. FN1, which were measured before by GC–MS. In addition, the fatty acids mainly appeared in the form of triglycerides, while they are in the methyl ester form in GC–MS. Therefore, it is not necessarily the case that all the detected compounds will appear in both techniques.

The freshwater microalga Scenedesmus sp. has been shown to have notable antimicrobial properties against a wide range of bacterial pathogens. It was reported that acetone, methanol, and dichloromethane extracts slightly inhibited the growth of Pseudomonas sp. and Xanthomonas oryzae, as did hot- and cold-water extracts (Beena and Krishnika, 2011) Moreover, the antimicrobial activity of Scenedesmus NT8c extracts was in accordance with Marrez et al. (2019) who reported that different organic extracts have shown considerable inhibition against S. aureus, E.coli, and S. typhi. In the present study, the 70% methanol extract of Scenedesmus sp. NT8C showed strong inhibition against gram-positive bacteria but not gram-negative bacteria. This is partially consistent with other studies conducted on the same species (Table 3).

On the other hand, it has been claimed that linolenic acid inhibits enoyl-acyl carrier protein reductase (FabI) in bacteria which plays a fundamental role in the synthesis and growth of bacterial fatty acids (Zheng et al., 2005). High amounts of linolenic acid were found in I. galbana, Scenedesmus sp. NT8c and Chlorella sp. FN1. This might indicate that these species have antimicrobial properties. In all cases, the antimicrobial activity was produced by intracellular extracts. Thus, the antimicrobial compounds must be extracted by an efficient method. However, disc-diffusion assays did not show zones of inhibition, probably because the concentration of those compounds was very low or they had low diffusion rates through the discs. Therefore, the spot-on-lawn method was adopted to show more antimicrobial activity and to confirm the findings, as it enabled direct contact between the compounds and the pathogens.

This study confirmed that all three species are capable of producing antimicrobial compounds in both laboratory and industrial-scale conditions after being grown outdoors. The findings also showed that some microalgal species can produce antimicrobial compounds in a commercial setting or they can be developed as food supplements or as biopreservatives.

5. Conclusion

This study demonstrates the proof-of-concept that microalgae have the potential to generate potent antimicrobial compounds that act against human and plant pathogens when extraction processes are performed using appropriate solvents and conditions. The study found that three species of microalgae can produce strong antimicrobial compounds that inhibit the growth of different species of pathogenic gram-positive bacteria. The inhibition activity was caused by unsaturated fatty acids and carotenoids – compounds that were extracted efficiently from the selected species. These bacteriostatic or bactericidal bioactive compounds may act independently or through synergistic actions, although their precise mechanism of action is still unknown. Therefore further scrutiny and investigation are required to help unravel the mechanisms of microalgae–microbe interactions at play. In summary, this study has paved the way towards demonstrating the presence and viability of potential high-value pharmaceutical antimicrobials with the prospect of large-scale production.

Declaration of Competing Interest

The authors declare no conflict of interest.

Acknowledgements

FS would like to thank Umm Al Qura University and the Saudi Arabian Government PhD scholarship programme for financial support. EC would like to thank the Australian Endeavour Leadership Programme for providing his PhD scholarship.

Footnotes

Peer review under responsibility of King Saud University.

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.jsps.2020.11.010.

Appendix A. Supplementary material

The following are the Supplementary data to this article:

Supplementary data 1
mmc1.docx (334.5KB, docx)

References

  1. Agoramoorthy G., et al. Antibacterial and antifungal activities of fatty acid methyl esters of the blind-your-eye mangrove from India. Braz. J. Microbiol. 2007;38(4):739–742. [Google Scholar]
  2. Alsenani F., et al. Transcriptome-wide analysis of Chlorella reveals auxin-induced carotenogenesis pathway in green microalgae. Algal Res. 2019;37:320–335. [Google Scholar]
  3. Arias C.A., Murray B.E. A new antibiotic and the evolution of resistance. N. Engl. J. Med. 2015;372(12):1168–1170. doi: 10.1056/NEJMcibr1500292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bashir K.M.I., et al. Estimation of Antibacterial Properties of Chlorophyta, Rhodophyta and Haptophyta Microalgae Spe. Microbiol. Biotechnol. Lett. 2018;46(3):225–233. [Google Scholar]
  5. Beena B., Krishnika A. Antibacterial activity of freshwater microalga (Scenedesmus sp.) against three bacterial strains. J. Biosci. Resourc. 2011;2(4):160–165. [Google Scholar]
  6. Benkendorff K., et al. Free fatty acids and sterols in the benthic spawn of aquatic molluscs, and their associated antimicrobial properties. J. Exp. Mar. Biol. Ecol. 2005;316(1):29–44. [Google Scholar]
  7. Berendonk T.U., et al. Tackling antibiotic resistance: the environmental framework. Nat. Rev. Microbiol. 2015;13(5):310–317. doi: 10.1038/nrmicro3439. [DOI] [PubMed] [Google Scholar]
  8. Bhattacharjee M. Pharmaceutically valuable bioactive compounds of algae. Asian J. Pharm. Clin. Res. 2016;7:43–47. [Google Scholar]
  9. Bose U., et al. LC-MS-Based metabolomics study of marine bacterial secondary metabolite and antibiotic production in Salinispora arenicola. Mar. Drugs. 2015;13(1):249–266. doi: 10.3390/md13010249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bruce D., et al. The identification of two antibacterial products of the marine planktonic alga Isochrysis galbana. Microbiology. 1967;48(2):293–298. doi: 10.1099/00221287-48-2-293. [DOI] [PubMed] [Google Scholar]
  11. Catarina Guedes, A., et al. (2011). Microalgal and cyanobacterial cell extracts for use as natural antibacterial additives against food pathogens 46(4), 862-870.
  12. Chua E.T., et al. The ionic liquid cholinium arginate is an efficient solvent for extracting high-value Nannochloropsis sp. lipids. J. ACS Sustain. Chem. Eng. 2018;7(2):2538–2544. [Google Scholar]
  13. Das B., et al. Production of antibacterials from the freshwater alga Euglena viridis (Ehren) World J. Microbiol. Biotechnol. 2005;21(1):45–50. [Google Scholar]
  14. Dilika F., et al. Antibacterial activity of linoleic and oleic acids isolated from Helichrysum pedunculatum: a plant used during circumcision rites. Fitoterapia. 2000;71(4):450–452. doi: 10.1016/s0367-326x(00)00150-7. [DOI] [PubMed] [Google Scholar]
  15. Dvoretsky D., et al. Experimental research into the antibiotic properties of chlorella vulgaris algal exometabolites. Chem. Eng. 2019;74 [Google Scholar]
  16. Exner M., et al. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? GMS Hygiene Infection Control. 2017;12 doi: 10.3205/dgkh000290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fábregas J., et al. In vitro inhibition of the replication of haemorrhagic septicaemia virus (VHSV) and African swine fever virus (ASFV) by extracts from marine microalgae. Antiviral Res. 1999;44(1):67–73. doi: 10.1016/s0166-3542(99)00049-2. [DOI] [PubMed] [Google Scholar]
  18. Faulkner D.J. Marine pharmacology. Antonie Van Leeuwenhoek. 2000;77(2):135–145. doi: 10.1023/a:1002405815493. [DOI] [PubMed] [Google Scholar]
  19. Galbraith, H., et al., 1971. Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol 34(4), 803-813. [DOI] [PubMed]
  20. Ghasemi Y., et al. Antifungal and antibacterial activity of the microalgae collected from paddy fields of Iran: characterization of antimicrobial activity of Chroococcus dispersus. J. Biol. Sci. 2007;7:904–910. [Google Scholar]
  21. Heath, R. J., et al., 2001. Lipid biosynthesis as a target for antibacterial agents 40(6), 467-497. [DOI] [PubMed]
  22. Jena, J., Subudhi, E., 2019. Microalgae: an untapped resource for natural antimicrobials. The role of microalgae in wastewater treatment, Springer: 99-114.
  23. Jørgensen E.G. Antibiotic substances from cells and culture solutions of unicellular algae with special reference to some chlorophyll derivatives. J. Phys. Plant. 1962;15(3):530–545. [Google Scholar]
  24. Jüttner F. Liberation of 5, 8, 11, 14, 17-eicosapentaenoic acid and other polyunsaturated fatty acids from lipids as a grazer defense reaction in epilithic diatom biofilms. J. Phycol. 2001;37(5):744–755. [Google Scholar]
  25. Kasanah N., et al. Antibacterial activity of Indonesian red algae Gracilaria edulis against bacterial fish pathogens and characterization of active fractions. Nat. Prod. Res. 2019;33(22):3303–3307. doi: 10.1080/14786419.2018.1471079. [DOI] [PubMed] [Google Scholar]
  26. Lee J.-B., et al. Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama Bay. Biol. Pharm. Bull. 2006;29(10):2135–2139. doi: 10.1248/bpb.29.2135. [DOI] [PubMed] [Google Scholar]
  27. Ma R., et al. LED power efficiency of biomass, fatty acid, and carotenoid production in Nannochloropsis microalgae. Bioresour. Technol. 2018;252:118–126. doi: 10.1016/j.biortech.2017.12.096. [DOI] [PubMed] [Google Scholar]
  28. Maadane A., et al. Antimicrobial activity of marine microalgae isolated from Moroccan coastlines. J. Microbiol., Biotechnol. Food Sci. 2020;9(5):1257–1260. [Google Scholar]
  29. Marrez D.A., et al. Antimicrobial and anticancer activities of Scenedesmus obliquus metabolites. Heliyon. 2019;5(3) doi: 10.1016/j.heliyon.2019.e01404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mendiola J.A., et al. Use of supercritical CO2 to obtain extracts with antimicrobial activity from Chaetoceros muelleri microalga. A correlation with their lipidic content. Eur. Food Res. Technol. 2007;224(4):505–510. [Google Scholar]
  31. Monnet D.L., et al. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect. Control Hosp. Epidemiol. 1998;19(06):388–394. doi: 10.1086/647837. [DOI] [PubMed] [Google Scholar]
  32. Najdenski H.M., et al. Antibacterial and antifungal activities of selected microalgae and cyanobacteria. J. Int. J. Food Sci. Technol. 2013;48(7):1533–1540. [Google Scholar]
  33. Navarro F., et al. Antimicrobial activity of the acidophilic eukaryotic microalga Coccomyxa onubensis. J. Phycol. Res. 2017;65(1):38–43. [Google Scholar]
  34. O’Neill, J., 2016. Tackling drug-resistant infections globally: final report and recommendations, Review on antimicrobial resistance.
  35. Organization, W. H., 2015. Investing to overcome the global impact of neglected tropical diseases: third WHO report on neglected tropical diseases 2015, World Health Organization.
  36. Otero P., et al. Pressurized liquid extraction (PLE) as an innovative green technology for the effective enrichment of Galician algae extracts with high quality fatty acids and antimicrobial and antioxidant properties. Mar. Drugs. 2018;16(5):156. doi: 10.3390/md16050156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Payne, D. J., et al., 2001. Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery 6(10), 537-544. [DOI] [PubMed]
  38. Pratt, R., et al., 1944. Chlorellin, an antibacterial substance from Chlorella. Science (Washington), 351-352. [DOI] [PubMed]
  39. Rodríguez-Meizoso I., et al. Subcritical water extraction and characterization of bioactive compounds from Haematococcus pluvialis microalga. J. Pharm. Biomed. Anal. 2010;51(2):456–463. doi: 10.1016/j.jpba.2009.03.014. [DOI] [PubMed] [Google Scholar]
  40. Rossolini G.M., et al. Update on the antibiotic resistance crisis. Curr. Opin. Pharmacol. 2014;18:56–60. doi: 10.1016/j.coph.2014.09.006. [DOI] [PubMed] [Google Scholar]
  41. Santoyo S., et al. Green processes based on the extraction with pressurized fluids to obtain potent antimicrobials from Haematococcus pluvialis microalgae. LWT-Food Sci. Technol. 2009;42(7):1213–1218. [Google Scholar]
  42. Schwartsmann G., et al. Marine organisms as a source of new anticancer agents. Lancet Oncol. 2001;2(4):221–225. doi: 10.1016/s1470-2045(00)00292-8. [DOI] [PubMed] [Google Scholar]
  43. Shin, S. Y., et al., 2007. Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria 113(2), 233-236. [DOI] [PubMed]
  44. Silhavy T.J., et al. The bacterial cell envelope. Cold Spring Harbor Perspect. Biol. 2010;2(5) doi: 10.1101/cshperspect.a000414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Skočibušić M., et al. Evaluation of antimicrobial potential of the marine Cyanobacterium, Rivularia mesenterica. J. Adv. Microbiol. 2019:1–11. [Google Scholar]
  46. Smith V.J., et al. Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar. Drugs. 2010;8(4):1213–1262. doi: 10.3390/md8041213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Srinivasakumar K., Rajashekhar M. In vitro studies on bactericidal activity and sensitivity pattern of isolated marine microalgae against selective human bacterial pathogens. Indian J. Sci. Technol. 2009;2(8):16–23. [Google Scholar]
  48. Stein J.R. CUP archive; 1973. Handbook of phycological methods: culture methods and growth measurements. [Google Scholar]
  49. Surendhiran D., et al. A green synthesis of antimicrobial compounds from marine microalgae Nannochloropsis oculata. J. Coastal Life Med. 2014;2(11):859–863. [Google Scholar]
  50. Terekhova V., et al. Influence of extrametabolites of marine microalgae on the reproduction of the bacterium Listeria monocytogenes. Russ. J. Mar. Biol. 2009;35(4):355–358. [Google Scholar]
  51. Topp E., et al. Antimicrobial resistance and the environment: assessment of advances, gaps and recommendations for agriculture, aquaculture and pharmaceutical manufacturing. FEMS Microbiol. Ecol. 2018;94(3):fix185. doi: 10.1093/femsec/fix185. [DOI] [PubMed] [Google Scholar]
  52. Verma E., et al. Structural elucidation and molecular docking of a novel antibiotic compound from cyanobacterium Nostoc sp. MGL001. Front. Microbiol. 2016;7:1899. doi: 10.3389/fmicb.2016.01899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Washida K., et al. Karatungiols A and B, two novel antimicrobial polyol compounds, from the symbiotic marine dinoflagellate Amphidinium sp. Tetrahedron Lett. 2006;47(15):2521–2525. [Google Scholar]
  54. Żak, A., et al., 2015. The influence of extracellular compounds produced by selected Baltic cyanobacteria, diatoms and dinoflagellates on growth of green algae Chlorella vulgaris 167, 113-118.
  55. Zheng C.J., et al. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 2005;579(23):5157–5162. doi: 10.1016/j.febslet.2005.08.028. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data 1
mmc1.docx (334.5KB, docx)

Articles from Saudi Pharmaceutical Journal : SPJ are provided here courtesy of Springer

RESOURCES